Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1249 - 1256 of 11616 results
PE Turns To Add-Ons With Large LBOs Out Of Reach
May 16, 2023| News
M&A Considerations For European Cos. Acquiring US Entities
May 16, 2023| News
As VC Deals Shrink, Convertible Fundraisings Are On The Rise
May 16, 2023| News
Texas Legislators Propose Onerous Permitting Requirements for Wind and Solar Renewable Energy Facilities
May 15, 2023| Alert| Viewpoint
Feds Can't Ditch Afghans' Challenge To US Parole Policy
May 15, 2023| News
Pfizer/Seagen And What May Follow
May 12, 2023| News
Form I-9 Requirement Flexibility Ending July 31, 2023
May 12, 2023| Alert| Viewpoint
Mintz May Madness: Tennessee’s Information Protection Act Gets Us Thinking About NIST(y) Safe Harbors
May 12, 2023| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.